These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 33540588)

  • 1. Interplay between ESKAPE Pathogens and Immunity in Skin Infections: An Overview of the Major Determinants of Virulence and Antibiotic Resistance.
    Vale de Macedo GHR; Costa GDE; Oliveira ER; Damasceno GV; Mendonça JSP; Silva LDS; Chagas VL; Bazán JMN; Aliança ASDS; Miranda RCM; Zagmignan A; Monteiro AS; Nascimento da Silva LC
    Pathogens; 2021 Feb; 10(2):. PubMed ID: 33540588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Light Modulates Important Pathogenic Determinants and Virulence in ESKAPE Pathogens Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus.
    Tuttobene MR; Pérez JF; Pavesi ES; Perez Mora B; Biancotti D; Cribb P; Altilio M; Müller GL; Gramajo H; Tamagno G; Ramírez MS; Diacovich L; Mussi MA
    J Bacteriol; 2021 Feb; 203(5):. PubMed ID: 33288627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cracking the Challenge of Antimicrobial Drug Resistance with CRISPR/Cas9, Nanotechnology and Other Strategies in ESKAPE Pathogens.
    Zohra T; Numan M; Ikram A; Salman M; Khan T; Din M; Salman M; Farooq A; Amir A; Ali M
    Microorganisms; 2021 Apr; 9(5):. PubMed ID: 33946643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the Evolutionary Conservation of Genes Encoding Multidrug Efflux Pumps in the ESKAPE Pathogens To Identify Antimicrobial Drug Targets.
    Brooks LE; Ul-Hasan S; Chan BK; Sistrom MJ
    mSystems; 2018; 3(3):. PubMed ID: 29719870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of Antimicrobial Resistance Levels of ESKAPE Microorganisms in a Peruvian IV-Level Hospital.
    Flores-Paredes W; Luque N; Albornoz R; Rojas N; Espinoza M; Pons MJ; Ruiz J
    Infect Chemother; 2021 Sep; 53(3):449-462. PubMed ID: 34508324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.
    Ma YX; Wang CY; Li YY; Li J; Wan QQ; Chen JH; Tay FR; Niu LN
    Adv Sci (Weinh); 2020 Jan; 7(1):1901872. PubMed ID: 31921562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escaping mechanisms of ESKAPE pathogens from antibiotics and their targeting by natural compounds.
    Jadimurthy R; Mayegowda SB; Nayak SC; Mohan CD; Rangappa KS
    Biotechnol Rep (Amst); 2022 Jun; 34():e00728. PubMed ID: 35686013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review.
    Mulani MS; Kamble EE; Kumkar SN; Tawre MS; Pardesi KR
    Front Microbiol; 2019; 10():539. PubMed ID: 30988669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens.
    Santajit S; Indrawattana N
    Biomed Res Int; 2016; 2016():2475067. PubMed ID: 27274985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and genotypic detection methods for antimicrobial resistance in ESKAPE pathogens (Review).
    Muntean MM; Muntean AA; Preda M; Manolescu LSC; Dragomirescu C; Popa MI; Popa GL
    Exp Ther Med; 2022 Aug; 24(2):508. PubMed ID: 35837033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coping with the ESKAPE pathogens: Evolving strategies, challenges and future prospects.
    Aloke C; Achilonu I
    Microb Pathog; 2023 Feb; 175():105963. PubMed ID: 36584930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent and Resistance Patterns of ESKAPE Pathogens Isolated in Pus Swabs from Hospitalized Patients.
    Masoud SS; Kovacevich A; Gangji R; Nyawale H; Nyange M; Ntukula A
    Can J Infect Dis Med Microbiol; 2022; 2022():3511306. PubMed ID: 36353409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
    Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance and Resistance of
    Ciofu O; Tolker-Nielsen T
    Front Microbiol; 2019; 10():913. PubMed ID: 31130925
    [No Abstract]   [Full Text] [Related]  

  • 15. An overview of resistance profiles ESKAPE pathogens from 2010-2015 in a tertiary respiratory center in Romania.
    Peneş NO; Muntean AA; Moisoiu A; Muntean MM; Chirca A; Bogdan MA; Popa MI
    Rom J Morphol Embryol; 2017; 58(3):909-922. PubMed ID: 29250670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of medicinal plants against ESKAPE: An update.
    Bhatia P; Sharma A; George AJ; Anvitha D; Kumar P; Dwivedi VP; Chandra NS
    Heliyon; 2021 Feb; 7(2):e06310. PubMed ID: 33718642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventilator-associated pneumonia caused by ESKAPE organisms: cause, clinical features, and management.
    Sandiumenge A; Rello J
    Curr Opin Pulm Med; 2012 May; 18(3):187-93. PubMed ID: 22366995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and clinical outcomes of ESKAPE bacteremia in solid organ transplantation and the risk factors for mortality.
    Ye QF; Zhao J; Wan QQ; Qiao BB; Zhou JD
    Transpl Infect Dis; 2014 Oct; 16(5):767-74. PubMed ID: 25124187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonribosomal peptide synthetase biosynthetic clusters of ESKAPE pathogens.
    Gulick AM
    Nat Prod Rep; 2017 Aug; 34(8):981-1009. PubMed ID: 28642945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting ESKAPE Pathogens: virulence, resistance, and combating strategies focusing on quorum sensing.
    Venkateswaran P; Vasudevan S; David H; Shaktivel A; Shanmugam K; Neelakantan P; Solomon AP
    Front Cell Infect Microbiol; 2023; 13():1159798. PubMed ID: 37457962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.